Cancer Research and Treatment

Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis

David E. Hinojosa-Gonzalez, Affan Zafar, Gal Saffati, Shane Kronstedt, Dimitar V. Zlatev, Mohit Khera

Prostate Cancer and Prostatic Diseases.2024;[Epub] CrossRef

Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies

Viswanath Das, John H. Miller, Charanraj Goud Alladi, Narendran Annadurai, Juan Bautista De Sanctis, Lenka Hrubá, Marián Hajdúch

Medicinal Research Reviews.2024;[Epub] CrossRef

Cognitive effects of long‐term androgen deprivation therapy in older men with prostate cancer

Denise Pergolizzi, Kathleen R. Flaherty, Rebecca M. Saracino, James C. Root, Elizabeth Schofield, Caroline Cassidy, Vani Katheria, Sunita K. Patel, William Dale, Christian J. Nelson

Psychosocial Factors Associated with Cognitive Function in Prostate Cancer Survivors on Hormonal Treatments: A Systematic Review

Lorna Pembroke, Kerry A. Sherman, Heather Francis, Haryana M. Dhillon, Howard Gurney, David Gillatt

A Systematic Review on the Potential Acceleration of Neurocognitive Aging in Older Cancer Survivors

Charlotte Kerstens, Hans P. M. W. Wildiers, Gwen Schroyen, Mercedes Almela, Ruth E. Mark, Maarten Lambrecht, Sabine Deprez, Charlotte Sleurs

Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial

Steven C. R. Williams, Ndaba Mazibuko, Owen O’Daly, Christian Zurth, Fiona Patrick, Christian Kappeler, Iris Kuss, Patricia E. Cole

Does ADT Influence the Risk of Suicidal Ideation among US Veteran Prostate Cancer Patients Pre-Exposed to PTSD?

Smit Brahmbhatt, Herta H. Chao, Shiv Verma, Sanjay Gupta

Androgen deprivation therapy and risk of cognitive dysfunction in men with prostate cancer: is there a possible link?

Myungsun Shim, Woo Jin Bang, Cheol Young Oh, Yong Seong Lee, Jin Seon Cho

Prostate International.2022; 10(1): 68. CrossRef

Impact of Testosterone on Alzheimer’s Disease

The World Journal of Men's Health.2022; 40(2): 243. CrossRef

Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer

Gregory L. Branigan, Georgina Torrandell‐Haro, Maira Soto, Edward P. Gelmann, Francesca Vitali, Kathleen E. Rodgers, Roberta Diaz Brinton

Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors

Jeffrey S. Wefel, Charles J. Ryan, Julie Van, James C. Jackson, Alicia K. Morgans

The Insignificant Correlation between Androgen Deprivation Therapy and Incidence of Dementia Using an Extension Survival Cox Hazard Model and Propensity-Score Matching Analysis in a Retrospective, Population-Based Prostate Cancer Registry

Young Ae Kim, Su-Hyun Kim, Jae Young Joung, Min Soo Yang, Joung Hwan Back, Sung Han Kim

Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions

David Conde-Estévez, Iván Henríquez, Jesús Muñoz-Rodríguez, Alejo Rodriguez-Vida

Expert Opinion on Drug Metabolism & Toxicology.2022; 18(9): 601. CrossRef

K. O. Kuznetsov, R. R. Khaidarova, R. H. Khabibullina, E. S. Stytsenko, V. I. Filosofova, I. R. Nuriakhmetova, E. M. Hisameeva, G. S. Vazhorov, F. R. Khaibullin, E. A. Ivanova, K. V. Gorbatova

Problems of Endocrinology.2022; 68(5): 97. CrossRef

Quantifying observational evidence for risk of dementia following androgen deprivation therapy for prostate cancer: an updated systematic review and meta-analysis

Haiying Cui, Yao Wang, Fei Li, Guangyu He, Zongmiao Jiang, Xiaokun Gang, Guixia Wang

Prostate Cancer and Prostatic Diseases.2021; 24(1): 15. CrossRef

Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor Inhibitors

Alicia K. Morgans, Joseph Renzulli, Kara Olivier, Neal D. Shore

Clinical Genitourinary Cancer.2021; 19(5): 467.e1. CrossRef

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer

Jui-Ming Liu, Chin-Yao Shen, Wallis C. Y. Lau, Shih-Chieh Shao, Kenneth K. C. Man, Ren-Jun Hsu, Chun-Te Wu, Edward Chia-Cheng Lai

Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function

A. B. Reiss, U. Saeedullah, D. J. Grossfeld, A. D. Glass, A. Pinkhasov, A. E. Katz

Clinical and Translational Oncology.2021; 24(5): 733. CrossRef

Biomarkers to Evaluate Androgen Deprivation Therapy for Prostate Cancer and Risk of Alzheimer’s Disease and Neurodegeneration: Old Drugs, New Concerns

Vérane Achard, Kelly Ceyzériat, Benjamin B. Tournier, Giovanni B. Frisoni, Valentina Garibotto, Thomas Zilli

Does androgen deprivation impact associations between cognition and strength, fitness and function in community-dwelling men with prostate cancer? A cross-sectional study

Niamh L Mundell, Patrick J Owen, Jack Dalla Via, Helen Macpherson, Robin M Daly, Steve F Fraser

Antiaging Therapies, Cognitive Impairment, and Dementia

Devin Wahl, Rozalyn M Anderson, David G Le Couteur, Rafael de Cabo

The Journals of Gerontology: Series A.2020; 75(9): 1643. CrossRef

A review of prostate cancer treatment impact on the CNS and cognitive function

Charles Ryan, Jeffrey S. Wefel, Alicia K. Morgans

Prostate Cancer and Prostatic Diseases.2020; 23(2): 207. CrossRef

Diagnostic accuracy of administrative database for bile duct cancer by ICD-10 code in a tertiary institute in Korea

Young-Jae Hwang, Seon Mee Park, Soomin Ahn, Jongchan Lee, Young Soo Park, Nayoung Kim

Hepatobiliary & Pancreatic Diseases International.2020; 19(6): 575. CrossRef

WITHDRAWN: The Changes of ADC Value, DCE-MRI Parameters and Their Influence on Neuropsychology in Prostate Cancer Patients after Endocrine Therapy Based on Magnetic Resonance Imaging

Neuroscience Letters.2020; : 135221. CrossRef

Neuropsychiatric Impact of Androgen Deprivation Therapy in Patients with Prostate Cancer: Current Evidence and Recommendations for the Clinician

Aisha L. Siebert, Leiszle Lapping-Carr, Alicia K. Morgans

European Urology Focus.2020; 6(6): 1170. CrossRef

An Updated Review: Androgens and Cognitive Impairment in Older Men

Frontiers in Endocrinology.2020;[Epub] CrossRef

Risk of dementia and Parkinson’s disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study

Myungsun Shim, Woo Jin Bang, Cheol Young Oh, Yong Seong Lee, Seong Soo Jeon, Hanjong Ahn, Young-Su Ju, Jin Seon Cho, Gianluigi Forloni

Androgen deprivation therapy for prostate cancer and risk of dementia

David Robinson, Hans Garmo, Mieke Van Hemelrijck, Jan‐Erik Damber, Ola Bratt, Lars Holmberg, Lars‐Olof Wahlund, Pär Stattin, Jan Adolfsson

Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer

Nirmish Singla, Rashed A. Ghandour, Ganesh V. Raj

Expert Opinion on Investigational Drugs.2019; 28(3): 249. CrossRef

Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis

Omar Saeed, Lori J. Bernstein, Rouhi Fazelzad, Mary Samuels, Lynn A. Burmeister, Lehana Thabane, Shereen Ezzat, David P. Goldstein, Jennifer Jones, Anna M. Sawka

Journal of Cancer Survivorship.2019; 13(2): 231. CrossRef

Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population‐based propensity score matching study

Bum Sik Tae, Byeong Jo Jeon, Hoon Choi, Jae Hyun Bae, Jae Young Park